Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion
Authors:
- Koichiro AbeKAKoichiro Abe
- Shuji SakaiSSShuji Sakai
Open Access
- 1 July 2015
- journal article
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (29) , e1010
Abstract
We investigated the role of F-18 fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) for the differential diagnosis of malignant and benign pleural effusion. We studied 36 consecutive patients with histologically proven cancer (excluding malignant mesothelioma) who underwent FDG-PET/CT for suspected malignant pleural effusion. Fourteen patients had cytologically proven malignant pleural effusion and the other 22 patients had either negative cytology or clinical follow-up, which confirmed the benign etiology. We examined the maximum standardized uptake values (SUV max) of pleural effusion and the target-to-normal tissue ratio (TNR), calculated as the ratio of the pleural effusion SUV max to the SUV mean of the normal tissues (liver, spleen, 12th thoracic vertebrae [Th12], thoracic aorta, and spinalis muscle). We also examined the size and density (in Hounsfield units) of the pleural effusion and pleural abnormalities on CT images. TNR (Th12) and increased pleural FDG uptake compared to background blood pool were significantly more frequent in cases with malignant pleural effusion (P < 0.05 for both). The cutoff TNR (Th12) value of >0.95 was the most accurate; the sensitivity, specificity, and accuracy for this value were 93%, 68%, and 75%, respectively. FDG-PET/CT can be a useful method for the differential diagnosis of malignant and benign pleural effusion.Keywords
This publication has 16 references indexed in Scilit:
- Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CTNuclear Medicine and Biology, 2013
- Hepatic FDG Uptake is not Associated with Hepatic Steatosis but with Visceral Fat Volume in Cancer ScreeningNuclear Medicine and Molecular Imaging, 2012
- 18F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancerNuklearmedizin-Nuclear Medicine, 2012
- Impact of Dual-Time-Point F-18 FDG PET/CT in the Assessment of Pleural Effusion in Patients With Non-Small-Cell Lung CancerClinical Nuclear Medicine, 2011
- Predictive Value of F-18 FDG PET/CT for Malignant Pleural Effusion in Non-Small Cell Lung Cancer PatientsOncology Research and Treatment, 2011
- Clinical significance of diffusely increased splenic uptake on FDG-PETNuclear Medicine Communications, 2009
- A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivityAnnals of Nuclear Medicine, 2009
- 18F-FDG PET imaging in assessing exudative pleural effusionsNuclear Medicine Communications, 2006
- Differentiation Between Malignant and Benign Pleural Effusion in Patients With Extra-Pleural Primary MalignanciesInvestigative Radiology, 2005
- FDG PET of Pleural Effusions in Patients with Non—Small Cell Lung CancerAmerican Journal of Roentgenology, 2000